Loss of libido in a woman with schizophrenia

American Journal of Psychiatry

Volumn 170, Issue 5, 2013, Pages 471-475

  Seeman, Mary V ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; PIMOZIDE; PROLACTIN; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CASE REPORT; CAUSAL ATTRIBUTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEMALE SEXUAL DYSFUNCTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LIBIDO DISORDER; LIFESTYLE MODIFICATION; MEDICAL DECISION MAKING; PATIENT INFORMATION; PRIORITY JOURNAL; PROLACTINOMA; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SEXUAL HEALTH; SIDE EFFECT; COUNSELING; DRUG EFFECT; LIBIDO; PSYCHOLOGICAL ASPECT; SEXUAL DYSFUNCTION;

ADULT; ANTIPSYCHOTIC AGENTS; COUNSELING; FEMALE; HUMANS; LIBIDO; SCHIZOPHRENIA; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

MLCS; MLOWN;

EID: 84879423944     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2012.12111475     Document Type: Article

References (45)

1. Sobecki JN, Curlin FA, Rasinski KA, Lindau ST: What we don't talk about when we don't talk about sex: results of a national survey of U.S. obstetrician/gynecologists. J Sex Med 2012; 9: 1285-1294
2. Coverdale JH, Balon R, Roberts LW: Teaching sexual historytaking: a systematic review of educational programs. Acad Med 2011; 86: 1590-1595
3. Cannon BJ, Kramer LM: Delusion content across the 20th century in an American psychiatric hospital. Int J Soc Psychiatry 2012; 58: 323-327
4. Bitzer J, Platano G, Tschudin S, Alder J: Sexual counseling for women in the context of physical diseases: a teaching model for physicians. J Sex Med 2007; 4: 29-37
5. Kelly DL, Conley RR: Sexuality and schizophrenia: a review. Schizophr Bull 2004; 30: 767-779
6. Nunes LVA, Moreira HC, Razzouk D, Nunes SOV, Mari J deJ: Strategies for the treatment of antipsychotic-induced sexual dysfunction and/or hyperprolactinemia among patients of the schizophrenia spectrum: a review. J Sex Marital Ther 2012; 38: 281-301
7. Marques TR, Smith S, Bonaccorso S, Gaughran F, Kolliakou A, Dazzan P, Mondelli V, Taylor H, DiForti M, McGuire PK, Murray RM, Howes OD: Sexual dysfunction in people with prodromal or first-episode psychosis. Br J Psychiatry 2012; 201: 131-136
8. Derogatis LR, Burnett AL: The epidemiology of sexual dysfunctions. J Sex Med 2008; 5: 289-300
9. Ambler DR, Bieber EJ, Diamond MP: Sexual function in elderly women: a review of current literature. Rev Obstet Gynecol 2012; 5: 16-27
10. Macdonald S, Halliday J, MacEwan T, Sharkey V, Farrington S, Wall S, McCreadie RG: Nithsdale Schizophrenia Surveys 24: sexual dysfunction: case-control study. Br J Psychiatry 2003; 182: 50-56
11. Giraldi A, Kristensen E: Sexual dysfunction in women with diabetes mellitus. J Sex Res 2010; 47: 199-211
12. Kolotkin RL, Binks M, Crosby RD, Østbye T, Gress RE, Adams TD: Obesity and sexual quality of life. Obesity (Silver Spring) 2006; 14: 472-479
13. Martelli V, Valisella S, Moscatiello S, Matteucci C, Lantadilla C, Costantino A, Pelusi G, Marchesini G, Meriggiola MC: Prevalence of sexual dysfunction among postmenopausal women with and without metabolic syndrome. J Sex Med 2012; 9: 434-441
14. Atlantis E, Sullivan T: Bidirectional association between depression and sexual dysfunction: a systematic review and metaanalysis. J Sex Med 2012; 9: 1497-1507
15. Günzler C, Berner MM: Efficacy of psychosocial interventions in men and women with sexual dysfunctions: a systematic review of controlled clinical trials, part 2: the efficacy of psychosocial interventions for female sexual dysfunction. J Sex Med 2012; 9: 3108-3125
16. Bains S, Shah AA: Sexual side effects of antipsychotic drugs. Advances in Pharmacoepidemiology and Drug Safety 2012; 1 (10.4172/2167-1052.1000109)
17. Byerly MJ, Nakonezny PA, Bettcher BM, Carmody T, Fisher R, Rush AJ: Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine. Schizophr Res 2006; 86: 244-250
18. Serretti A, Chiesa A: A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int Clin Psychopharmacol 2011; 26: 130-140
19. Malik P, Kemmler G, Hummer M, Riecher-Roessler A, Kahn RS, Fleischhacker WW; and the EUFEST Study Group: Sexual dysfunction in first-episode schizophrenia patients: results from European First Episode Schizophrenia Trial. J Clin Psychopharmacol 2011; 31: 274-280
20. Wang AT, Mullan RJ, Lane MA, Hazem A, Prasad C, Gathaiya NW, Fernández-Balsells MM, Bagatto A, Coto-Yglesias F, Carey J, Elraiyah TA, Erwin PJ, Gandhi GY, Montori VM, Murad MH: Treatment of hyperprolactinemia: a systematic review and metaanalysis. Syst Rev 2012; 1: 33
21. Jayyab AA: Taurine implicated in bromocriptine induced hallucination: glycine-glutamic-aspartic implicated in bromocriptine induced schizophrenia. Am J Pharmacol Toxicol 2010; 5: 34-41
22. Schmidt HM, Hagen M, Kriston L, Soares-Weiser K, Maayan N, Berner MM: Management of sexual dysfunction due to antipsychotic drug therapy. Cochrane Database Syst Rev 2012; 11:CD003546
23. Seeman MV: Preventing breast cancer in women with schizophrenia. Acta Psychiatr Scand 2011; 123: 107-117
24. Faupel-Badger JM, Sherman ME, Garcia-Closas M, Gaudet MM, Falk RT, Andaya A, Pfeiffer RM, Yang XR, Lissowska J, Brinton LA, Peplonska B, Vonderhaar BK, Figueroa JD: Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland. Br J Cancer 2010; 103: 1097-1102
25. Inder WJ, Castle D: Antipsychotic-induced hyperprolactinaemia. Aust N Z J Psychiatry 2011; 45: 830-837
26. Byerly MJ, Marcus RN, Tran Q-V, Eudicone JM, Whitehead R, Baker RA: Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study. Schizophr Res 2009; 107: 218-222
27. Dickson RA, Seeman MV, Corenblum B. Hormonal side effects in women: typical versus atypical antipsychotic treatment. J Clin Psychiatry 2000; 61(suppl 3): 10-15
28. Riecher-Rössler A, Schmid C, Bleuer S, Birkhäuser M: [Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy]. Neuropsychiatr 2009; 23: 71-83 (German)
29. Vigod SN, Seeman MV, Ray JG, Anderson GM, Dennis CL, Grigoriadis S, Gruneir A, Kurdyak PA, Rochon PA: Temporal trends in general and age-specific fertility rates among women with schizophrenia (1996-2009): a population-based study in Ontario, Canada. Schizophr Res 2012; 139: 169-175
30. Seeman MV: Antipsychotic-induced amenorrhea. J Ment Health 2011; 20: 484-491
31. Coverdale JH, Bayer TL, McCullough LB, Chervenak FA: Respecting the autonomy of chronic mentally ill women in decisions about contraception. Hosp Community Psychiatry 1993; 44: 671-674
32. Greydanus DE, Pratt HD, Patel DR: Concepts of contraception for adolescent and young adult women with chronic illness and disability. Dis Mon 2012; 58: 258-320
33. Seeman MV, Ross R: Prescribing contraceptives for women with schizophrenia. J Psychiatr Pract 2011; 17: 258-269
34. Trussell J: Contraceptive failure in the United States. Contraception 2011; 83: 397-404
35. Lee M, Morgan M, Rapkin A: Clitoral and vulvar vestibular sensation in women taking 20 mcg ethinyl estradiol combined oral contraceptives: a preliminary study. J Sex Med 2011; 8: 213-218
36. Gearing RE, Alonzo D, Marinelli C: Maternal schizophrenia: psychosocial treatment for mothers and their children. Clin Schizophr Relat Psychoses 2012; 6: 27-33
37. Gentile S: Antipsychotic therapy during early and late pregnancy: a systematic review. Schizophr Bull 2010; 36: 518-544
38. Gentile S: Neurodevelopmental effects of prenatal exposure to psychotropic medications. Depress Anxiety 2010; 27: 675-686
39. Nicholson J, Hinden BR, Biebel K, Henry AD, Katz-Leavy J: A qualitative study of programs for parents with serious mental illness and their children: building practice-based evidence. J Behav Health Serv Res 2007; 34: 395-413
40. Seeman MV: Clinical interventions for women with schizophrenia: pregnancy. Acta Psychiatr Scand 2013; 127: 12-22
41. Seeman MV: Parenting issues in mothers with schizophrenia. Curr Womens Health Rev 2010; 6: 51-57
42. Lagan M, Knights K, Barton J, Boyce PM: Advocacy for mothers with psychiatric illness: a clinical perspective. Int J Ment Health Nurs 2009; 18: 53-61
43. Seeman MV: Intervention to prevent child custody loss in mothers with schizophrenia. Schizophr Res Treatment 2012; 2012: 796763
44. McCullough LB, Coverdale JH, Chervenak FA: Ethical challenges of decision making with pregnant patients who have schizophrenia. Am J Obstet Gynecol 2002; 187: 696-702
45. Miller LJ: Ethical issues in perinatal mental health. Psychiatr Clin North Am 2009; 32: 259-270